Lymphocyte subsets in alcoholic liver disease

World Journal of Hepatology

Volumn 5, Issue 2, 2013, Pages 46-55

  Matos, Luís Costa ^a,b   Batista, Paulo ^b   Monteiro, Nuno ^b   Ribeiro, João ^b   Cipriano, Maria A ^c   Henriques, Pedro ^b   Girão, Fernando ^b   Carvalho, Armando ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Viseu EPE ^*  (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alcoholic liver disease; Alcoholism; Flow cytometry; HFE gene; Liver biopsy; Liver fibrosis; Lymphocyte subsets

Indexed keywords

EID: 84879177925     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v5.i2.46     Document Type: Article

References (58)

1. World Health Organization. Global Status Report on Alcohol and Health 2011. WHO Library, 2011: 20-37
2. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-1360 [PMID: 12423980 DOI: 10.1016/S0140-6736(02)11403-6]
3. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis 1988; 8: 12-25 [PMID: 3283941 DOI: 10.1055/s-2008-1040525]
4. McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 2022-2036 [PMID: 9820369 DOI: 10.1111/j.1572-0241.1998.00587.x]
5. Pequignot G, Cyrulnik F. Chronic disease due to overconsumption of alcoholic drinks (excepting neuropsychiatric pathology). In: International Encyclopaedia of Pharmacology and Therapeutics, vol II. Pergamon Press, 1970: 375-412
6. Sherlock S, Dooley J. Diseases of the liver and billiary system. 11th ed. Blackwell Pub, 2002: 381-398
7. MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis 1986; 6: 221-232 [PMID: 3022386 DOI: 10.1055/s-2008-1040605]
8. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005; 9: 37-53 [PMID: 15763228 DOI: 10.1016/ j.cld.2004.11.001]
9. Costa Matos L. [Alcoholic Liver Disease]. An. Med. Interna 2006; 13: 207-216
10. Yerian L. Histopathological evaluation of fatty and alcoholic liver diseases. J Dig Dis 2011; 12: 17-24 [PMID: 21091934 DOI: 10.1111/j.1751-2980.2010.00472.x]
11. Van Pelt FN, Straub P, Manns MP. Molecular basis of druginduced immunological liver injury. Semin Liver Dis 1995; 15: 283-300 [PMID: 7491507]
12. Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F, Kang YJ, Keshavarzian A, Rao R, Sartor RB, Swanson C, Turner JR. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 2008; 42: 349-361 [PMID: 18504085 DOI: 10.1016/j.alcohol.2008.03.131]
13. Thurman RG. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998; 275: G605-G611 [PMID: 9756487]
14. Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A. The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int 2010; 4: 659-672 [PMID: 21286336 DOI: 10.1007/s12072-010-9219-x]
15. Han DW. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 2002; 8: 961-965 [PMID: 12439906]
16. Neuman MG. Cytokines--central factors in alcoholic liver disease. Alcohol Res Health 2003; 27: 307-316 [PMID: 15540802]
17. Bharrhan S, Koul A, Chopra K, Rishi P. Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model. PLoS One 2011; 6: e20635 [PMID: 21673994 DOI: 10.1371/journal. pone.0020635]
18. Macgeorge J, Frazer IH, Cunningham A. Autoantibodies, sheep cell agglutinins and anti-albumin antibodies in alcoholic liver disease. J Clin Lab Immunol 1984; 13: 21-24 [PMID: 6609235]
19. Laskin CA, Vidins E, Blendis LM, Soloninka CA. Autoantibodies in alcoholic liver disease. Am J Med 1990; 89: 129-133 [PMID: 2382661 DOI: 10.1016/0002-9343(90)90288-O]
20. Perperas A, Tsantoulas D, Portmann B, Eddleston AL, Williams R. Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut 1981; 22: 149-152 [PMID: 7215946 DOI: 10.1136/gut.22.2.149]
21. McFarlane IG. Autoantibodies in alcoholic liver disease. Addict Biol 2000; 5: 141-151 [PMID: 20575828]
22. Chedid A, Chadalawada KR, Morgan TR, Moritz TE, Mendenhall CL, Hammond JB, Emblad PW, Cifuentes DC, Kwak JW, Gilman-Sachs A. Phospholipid antibodies in alcoholic liver disease. Hepatology 1994; 20: 1465-1471 [PMID: 7982646 DOI: 10.1002/hep.1840200614]
23. Szabo G, Mandrekar P, Oak S, Mayerle J. Effect of ethanol on inflammatory responses. Implications for pancreatitis. Pancreatology 2007; 7: 115-123 [PMID: 17592223 DOI: 10.1159/000104236]
24. Lau AH, Szabo G, Thomson AW. Antigen-presenting cells under the influence of alcohol. Trends Immunol 2009; 30: 13-22 [PMID: 19059005 DOI: 10.1016/j.it.2008.09.005]
25. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408 [PMID: 8696333 DOI: 10.1038/ng0896-399]
26. Aranda N, Viteri FE, Montserrat C, Arija V. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain. Ann Hematol 2010; 89: 767-773 [PMID: 20107990 DOI: 10.1007/s00277-010-0901-9]
27. Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a comorbid factor in nonhemochromatotic liver disease. Alcohol 2003; 30: 137-144 [PMID: 12957298 DOI: 10.1016/ S0741-8329(03)00127-7]
28. Wallace DF, Subramaniam VN. Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron. Biochim Biophys Acta 2009; 1790: 663-670 [PMID: 18848602 DOI: 10.1016/j.bbagen.2008.09.002]
29. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp- Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321 [PMID: 15915461 DOI: 10.1002/hep.20701]
30. Couzigou P, Vincendeau P, Fleury B, Richard-Molard B, Pierron A, Bergeron JL, Bezian JH, Amouretti M, Béraud C. [Changes in circulating lymphocyte subsets in alcoholic hepatopathies. Respective role of alcohol, hepatocellular insufficiency and malnutrition]. Gastroenterol Clin Biol 1984; 8: 915-919 [PMID: 6519399]
31. Spinozzi F, Rambotti P, Gerli R, Cernetti C, Rondoni F, Frascarelli A, Bertotto A, Grignani F. Immunoregulatory T cells in alcoholic liver disease: phenotypical dissection of circulating Leu3+/T4+ inducer T-lymphocytes. J Clin Lab Immunol 1987; 23: 161-167 [PMID: 2959783]
32. Naude CE, Bouic P, Senekal M, Kidd M, Ferrett HL, Fein G, Carey PD. Lymphocyte measures in treatment-nal̈ve 13-15-year old adolescents with alcohol use disorders. Alcohol 2011; 45: 507-514 [PMID: 21624786 DOI: 10.1016/ j.alcohol.2011.02.307]
33. Müller C, Wolf H, Göttlicher J, Eibl MM. Helper-inducer and suppressor-inducer lymphocyte subsets in alcoholic cirrhosis. Scand J Gastroenterol 1991; 26: 295-301 [PMID: 1830163 DOI: 10.3109/00365529109025045]
34. Laso FJ, Madruga JI, López A, Ciudad J, Alvarez-Mon M, San Miguel J, Orfao A. Distribution of peripheral blood lymphoid subsets in alcoholic liver cirrhosis: influence of ethanol intake. Alcohol Clin Exp Res 1996; 20: 1564-1568 [PMID: 8986204 DOI: 10.1111/j.1530-0277.1996.tb01700.x]
35. Lombardo L, Capaldi A, Poccardi G, Vineis P. Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis. Int J Clin Lab Res 1995; 25: 153-156 [PMID: 8562979 DOI: 10.1007/BF02592558]
36. Cook RT, Garvey MJ, Booth BM, Goeken JA, Stewart B, Noel M. Activated CD-8 cells and HLA DR expression in alcoholics without overt liver disease. J Clin Immunol 1991; 11: 246-253 [PMID: 1839029 DOI: 10.1007/BF00918182]
37. Arosa FA, Porto G, Cabeda JM, Lacerda R, Resende D, Cruz E, Cardoso C, Fonseca M, Simões C, Rodrigues P, Bravo F, Oliveira JC, Alves H, Fraga J, Justiça B, de Sousa M. Expansions of CD8+CD28- and CD8+TcRVbeta5.2+ T cells in peripheral blood of heavy alcohol drinkers. Alcohol Clin Exp Res 2000; 24: 519-527 [PMID: 10798589 DOI: 10.1111/ j.1530-0277.2000.tb02020.x]
38. Cook RT, Ballas ZK, Waldschmidt TJ, Vandersteen D, La- Brecque DR, Cook BL. Modulation of T-cell adhesion markers, and the CD45R and CD57 antigens in human alcoholics. Alcohol Clin Exp Res 1995; 19: 555-563 [PMID: 7573774 DOI: 10.1111/j.1530-0277.1995.tb01548.x]
39. Schirren CA, Jung MC, Zachoval R, Diepolder H, Hoffmann R, Riethmüller G, Pape GR. Analysis of T cell activation pathways in patients with liver cirrhosis, impaired delayed hypersensitivity and other T cell-dependent functions. Clin Exp Immunol 1997; 108: 144-150 [PMID: 9097923 DOI: 10.1046/j.1365-2249.1997.d01-985.x]
40. Ye C, Li WY, Zheng MH, Chen YP. T-helper 17 cell: A distinctive cell in liver diseases. Hepatol Res 2011; 41: 22-29 [PMID: 21108703 DOI: 10.1111/j.1872-034X.2010.00744.x]
41. Patsenker E, Stickel F. Role of integrins in fibrosing liver diseases. Am J Physiol Gastrointest Liver Physiol 2011; 301: G425-G434 [PMID: 21659620 DOI: 10.1152/ajpgi.00050.2011]
42. Cook RT, Waldschmidt TJ, Cook BL, Labrecque DR, McLatchie K. Loss of the CD5+ and CD45RAhi B cell subsets in alcoholics. Clin Exp Immunol 1996; 103: 304-310 [PMID: 8565316 DOI: 10.1046/j.1365-2249.1996.d01-621.x]
43. Laso FJ, Madruga JI, Girón JA, López A, Ciudad J, San Miguel JF, Alvarez-Mon M, Orfao A. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology 1997; 25: 1096-1100 [PMID: 9141423 DOI: 10.1002/hep.510250508]
44. Iredale JP. Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 2001; 21: 427-436 [PMID: 11586470 DOI: 10.1055/s-2001-17557]
45. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-depen- dent manners. Gastroenterology 2006; 130: 435-452 [PMID: 16472598 DOI: 10.1053/j.gastro.2005.10.055]
46. Jeong WI, Gao B. Innate immunity and alcoholic liver fibrosis. J Gastroenterol Hepatol 2008; 23 Suppl 1: S112-S118 [PMID: 18336653 DOI: 10.1111/j.1440-1746.2007.05274.x]
47. Byun JS, Jeong WI. Involvement of hepatic innate immunity in alcoholic liver disease. Immune Netw 2010; 10: 181-187 [PMID: 21286378 DOI: 10.4110/in.2010.10.6.181]
48. Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 2008; 134: 248-258 [PMID: 18166357 DOI: 10.1053/ j.gastro.2007.09.034]
49. Arteel GE. Silencing a killer among us: ethanol impairs immune surveillance of activated stellate cells by natural killer cells. Gastroenterology 2008; 134: 351-353 [PMID: 18166364 DOI: 10.1053/j.gastro.2007.11.061]
50. Muhanna N, Doron S, Wald O, Horani A, Eid A, Pappo O, Friedman SL, Safadi R. Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis. Hepatology 2008; 48: 963-977 [PMID: 18726940 DOI: 10.1002/hep.22413]
51. Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, Friedman SL. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin- 10 from hepatocytes. Gastroenterology 2004; 127: 870-882 [PMID: 15362042 DOI: 10.1053/j.gastro.2004.04.062]
52. Arosa FA, da Silva AJ, Godinho IM, ter Steege JC, Porto G, Rudd CE, de Sousa M. Decreased CD8-p56lck activity in peripheral blood T-lymphocytes from patients with hereditary haemochromatosis. Scand J Immunol 1994; 39: 426-432 [PMID: 8191217 DOI: 10.1111/j.1365-3083.1994.tb03396.x]
53. Arosa FA, Oliveira L, Porto G, da Silva BM, Kruijer W, Veltman J, de Sousa M. Anomalies of the CD8+ T cell pool in haemochromatosis: HLA-A3-linked expansions of CD8+CD28- T cells. Clin Exp Immunol 1997; 107: 548-554 [PMID: 9067531 DOI: 10.1046/j.1365-2249.1997.d01-967.x]
54. Cardoso C, Porto G, Lacerda R, Resende D, Rodrigues P, Bravo F, Oliveira JC, Justiça B, de Sousa M. T-cell receptor repertoire in hereditary hemochromatosis: a study of 32 hemochromatosis patients and 274 healthy subjects. Hum Immunol 2001; 62: 488-499 [PMID: 11334672 DOI: 10.1016/ S0198-8859(01)00233-6]
55. Cruz E, Vieira J, Gonçalves R, Alves H, Almeida S, Rodrigues P, Lacerda R, Porto G. Involvement of the major histocompatibility complex region in the genetic regulation of circulating CD8 T-cell numbers in humans. Tissue Antigens 2004; 64: 25-34 [PMID: 15191520 DOI: 10.1111/ j.1399-0039.2004.00245.x]
56. Macedo MF, Porto G, Costa M, Vieira CP, Rocha B, Cruz E. Low numbers of CD8+ T lymphocytes in hereditary haemochromatosis are explained by a decrease of the most mature CD8+ effector memory T cells. Clin Exp Immunol 2010; 159: 363-371 [PMID: 20015273 DOI: 10.1111/ j.1365-2249.2009.04066.x]
57. Cardoso EM, Hagen K, de Sousa M, Hultcrantz R. Hepatic damage in C282Y homozygotes relates to low numbers of CD8+ cells in the liver lobuli. Eur J Clin Invest 2001; 31: 45-53 [PMID: 11168438 DOI: 10.1046/j.1365-2362.2001.00744.x]
58. Cruz E, Melo G, Lacerda R, Almeida S, Porto G. The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects. Blood Cells Mol Dis 2006; 37: 33-39 [PMID: 16762569]